KLP Kapitalforvaltning AS Makes New $6.43 Million Investment in STERIS plc (NYSE:STE)

KLP Kapitalforvaltning AS purchased a new stake in STERIS plc (NYSE:STEFree Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 31,300 shares of the medical equipment provider’s stock, valued at approximately $6,434,000.

A number of other institutional investors have also made changes to their positions in STE. Raymond James Financial Inc. acquired a new stake in STERIS in the 4th quarter valued at approximately $223,987,000. Franklin Resources Inc. boosted its position in shares of STERIS by 171.2% in the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock valued at $191,370,000 after acquiring an additional 529,308 shares during the period. Boston Trust Walden Corp grew its stake in shares of STERIS by 400.4% in the fourth quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider’s stock worth $46,198,000 after acquiring an additional 179,829 shares during the last quarter. Swedbank AB bought a new position in STERIS during the third quarter worth $28,251,000. Finally, Benjamin Edwards Inc. raised its stake in STERIS by 2,123.2% during the 3rd quarter. Benjamin Edwards Inc. now owns 113,672 shares of the medical equipment provider’s stock valued at $27,574,000 after purchasing an additional 108,559 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on STE. Stephens restated an “overweight” rating and set a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. Finally, Piper Sandler raised their price objective on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $258.75.

Get Our Latest Research Report on STERIS

STERIS Stock Down 0.6 %

Shares of STE opened at $221.57 on Wednesday. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The stock has a market cap of $21.77 billion, a price-to-earnings ratio of 47.04 and a beta of 0.92. The company has a 50-day moving average price of $221.62 and a two-hundred day moving average price of $221.60. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STEGet Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Equities analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were given a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is currently 48.41%.

About STERIS

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Further Reading

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STEFree Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.